Levetiracetam Cf (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and decreases abnormal electrical activity in the brain, thereby preventing the initiation and spread of seizures.

The appropriate dose of levetiracetam is determined individually by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are made to achieve optimal seizure control while minimizing side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and discuss alternative options. Women who are pregnant or planning to become pregnant should consult their prescriber before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a favorable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen for its broad spectrum of activity and ease of dosing, though individual response varies.

Levetiracetam Cf should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

Levetiracetam Cf is taken orally, usually with or without food, as directed by the prescriber. Tablets or capsules are swallowed whole with a glass of water, and the dosing schedule is individualized for each patient.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, suicidal thoughts or behaviors, and rare blood disorders like neutropenia. Patients should seek immediate medical attention if they experience rash, mood changes, or signs of infection.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that may reduce its effectiveness.